CardioLink Medical Recognized as Guangdong Provincial Engineering Technology Research Center for Oncology Interventional Devices

Recently, the Science and Technology Department of Guangdong Province officially released2024Year“Guangdong Provincial Engineering Technology Research Center”List of Recognitions, Cardiolink Science has successfully been recognized for its strong R&D capabilities and outstanding innovation in the field of tumor intervention."Guangdong Provincial Engineering Research Center for Tumor Interventional Medical Devices," this honor marks that Cardiolink Science has reached a new height in technological innovation, achievement transformation, and industry leadership.

Focus on the FrontierB-E-S-TR&D and Manufacturing Technology Platform

CompanyThe founding team consists of clinicians and elites in medical device research and development, with“Therapy Reading”Driven by,By constructingFull-stackB-E-S-TR&D and Manufacturing Technology Platform, seamlessly connecting technical engineering language with clinical needs, and promotingFull-process technological innovation and continuous product iteration。

Promote the Deep Integration of Industry, Academia, and Research

The company focuses on industry-university-research cooperation, deepening exchanges and collaboration with well-known research institutes such as the Chinese Academy of Sciences and Capital Medical University, promoting integrated innovation in industry-university-research; actively participating in industry research projects, asThe lead organization collaborates with renowned universities and research institutes to undertake major scientific and technological projects from the Shenzhen Science and Technology Innovation Commission, achieving university-enterprise cooperation and mutual benefits in production and education.

Strengthen the Output of Scientific Research Achievements

The company upholds"Therapy Reading" Innovation Drives High-Quality Development, Focusing on the Pan-Vascular Intervention Field and Concentrating on Tumor Interventional Treatment, Effectively Enhancing the Company's Independent R&D Capabilities and Innovation. To date, the company has applied for more than [number] patents in China.170Items, including authorized invention patents25Item; AppliedPCT6Items, U.S., European, Singaporean, and Brazilian invention patents each1Item.

Introduction to Guangdong Provincial Engineering Technology Research Center

The Engineering Technology Research Center of Guangdong Province is an important component of Guangdong's scientific and technological innovation system, aiming to build a technology innovation system that is enterprise-oriented, market-driven, and deeply integrated with industry, academia, and research. This qualification certification selects innovative entities within the province that possess significant technical R&D capabilities, technical problem-solving abilities, and industrialization transformation advantages, providing strong support for the construction of a modern industrial system.